Issue of Equity

RNS Number:8872J
ReGen Therapeutics PLC
10 April 2003


           

ReGen Therapeutics Plc


10 April 2003



INTERIM FUNDING


ReGen Therapeutics Plc ("ReGen" or the "Company") announces that it has today
placed 32,793,333 new ordinary shares ("New Shares") with new and existing
shareholders at 0.75p per share raising the Company #245,950 by way of
additional working capital.


Application will be made for the New Shares to be admitted to the Alternative
Investment Market of the London Stock Exchange plc and dealings are expected to
commence at 8.00 am on 24 April 2003.


Executive Chairman Percy Lomax said, "This fundraising, as part of our
continuing fundraising efforts, illustrates the continued support for the
Company in these very difficult market conditions. It will help, along with our
recently acquired investment trust shares, to provide funding for our ongoing
development programme. We also now continue to explore further fundraising and
acquisition opportunities."

For further information please contact:

Andrew Marshall

Marshall Robinson Roe

Tel No 020 7489 2033







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
IOESFIFESSDSEFL